BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 4:06:00 PM | Browse: 484 | Download: 407
Publication Name World Journal of Gastroenterology
Manuscript ID 7108
Country/Territory United Kingdom
2013-11-05 10:15
Peer-Review Started
2013-11-05 15:32
To Make the First Decision
2013-12-04 09:16
Return for Revision
2013-12-05 19:37
2013-12-27 01:17
Second Decision
2014-03-13 13:55
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-13 16:40
Articles in Press
2014-05-23 11:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-30 09:45
Publish the Manuscript Online
2014-07-26 13:36
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Meta-Analysis
Article Title Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus
Manuscript Source Invited Manuscript
All Author List Piers Gatenby, Christine Caygill, Christine Wall, Santanu Bhatacharjee, James Ramus, Anthony Watson and Marc Winslet
Funding Agency and Grant Number
Funding Agency Grant Number
Barrett’s Oesophagus Campaign
Wexham Gastrointestinal Trust
Childwick Trust
RL St J Harmsworth Memorial Research Fund
David and Frederick Barclay Foundation
Corresponding author Piers Gatenby, MD, Division of Surgery and Interventional Science, UCL, Royal Free Campus, Pond Street, London, NW32QG, United Kingdom. p.gatenby@ucl.ac.uk
Keywords Barrett esophagus; Esophageal neoplasms; Forecasting; Meta-analysis; Cohort studies
Core Tip The mean life expectancy for patients at diagnosis of Barrett’s esophagus is 22 years. Based on current estimates for high-grade dysplasia and adenocarcinoma incidence, the lifetime risk of requiring an intervention for high-grade dysplasia or adenocarcinoma development based on data from recent meta-analyses is 1 in 5 to 1 in 6 and based on data from recent population-based studies is between 1 in 8 and 1 in 20.
Publish Date 2014-07-26 13:36
Citation Gatenby P, Caygill C, Wall C, Bhatacharjee S, Ramus J, Watson A, Winslet M. Lifetime risk of esophageal adenocarcinoma in patients with Barrett’s esophagus. World J Gastroenterol 2014; 20(28): 9611-9617
Url http://www.wjgnet.com/1007-9327/full/v20/i28/9611.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i28.9611
Full Article (PDF) WJG-20-9611.pdf
Full Article (Word) WJG-20-9611.doc
Manuscript File 7108-Review.docx
Answering Reviewers 7108-Answering reviewers.pdf
Copyright License Agreement 7108-Copyright assignment.pdf
Peer-review Report 7108-Peer reviewer(s).pdf
Scientific Editor Work List 7108-Scientific editor work list.doc